Prescription drugs prices in the United States have long operated behind closed doors. Prescription drug price transparency laws are changing that — requiring manufacturers, pharmacies, and pharmacy benefit managers to disclose pricing data to regulators. This guide explains how these laws work and what they mean for what you pay at the pharmacy.
For real-time price comparison at pharmacies near you, use RxDiff — the patient-facing side of drug pricing transparency.
Drug pricing transparency refers to laws requiring pharmaceutical manufacturers, PBMs, insurers, and other supply chain entities to disclose prescription drug pricing data to state or federal regulators. The goal is to reveal the gap between a drug's list price, the rebates negotiated by PBMs, and what patients and health plans actually pay — making drug costs visible enough to support meaningful reform.
Prescription drug prices pass through multiple layers before reaching patients. The manufacturer sets a wholesale acquisition cost (WAC). These companies negotiate rebates in exchange for formulary placement. Those rebates often don't reduce what patients pay at the counter. Transparency laws aim to make this supply chain visible to regulators — and increasingly, to patients.
Several federal laws now require prescription drug price transparency reporting. The Consolidated Appropriations Act requires health plans to report drug spending to HHS. The Inflation Reduction Act established Medicare drug price negotiation authority — the first time the federal government can directly negotiate prescription drug costs — and requires manufacturers to provide detailed pricing data as part of that process. Visit CMS.gov for details on the Medicare Drug Price Negotiation Program and current requirements.
Federal PBM transparency requirements have also expanded. These administrators must now provide more information to plan sponsors about fees, payment arrangements, and actual drug costs — increasing visibility across the entire supply chain. This data helps employers identify whether these practices are inflating their pharmacy spend.
Many states have passed prescription drug price transparency acts requiring manufacturers to provide advance notice of high price increases, submit annual reports on pricing factors, and disclose data to state health regulators. The National Academy for State Health Policy (NASHP) tracks state-by-state drug price transparency laws, covering what entities must report, how far in advance price increases must be disclosed, and what data is collected.
States with strong drug pricing transparency acts — including Oregon, California, and Minnesota — require manufacturers to report: wholesale acquisition cost of new drugs, reasons for price increases above a threshold, research and development costs, and rebate structures. This data builds the foundation for policies that can actually control prescription drug costs over time.
Transparency laws don't lower drug costs overnight — but they create the conditions for change:
While systemic transparency builds over time, patients can act now. RxDiff, GoodRx, and similar platforms already make drug pricing visible at the pharmacy level — showing you what different pharmacies charge for the same medication so you can choose the lowest price before filling. Your insurer's member portal may also show your expected out-of-pocket cost before you fill.
See real drug prices at pharmacies near you — transparent and free on RxDiff.
Compare Drug Prices on RxDiff →What is a prescription drug pricing disclosure law?
A prescription drug pricing transparency law requires manufacturers, PBMs, or insurers to disclose pricing data to state or federal regulators. These laws aim to make the gap between list prices, rebates, and patient costs visible — creating the data foundation for policy actions that can control prescription drug costs over time.
What do drug pricing transparency laws require manufacturers to report?
State and federal transparency acts typically require manufacturers to report: wholesale acquisition cost of new drugs, advance notice of significant price increases (often 60 days), reasons for price increases, research and development costs, and rebate structures. Requirements vary by jurisdiction.
How do PBM transparency requirements work?
PBM transparency laws require disclosure of manufacturer payments, health plan fees, and the spread between pharmacy reimbursements and plan charges. This information helps employers and regulators identify PBM practices that may be inflating prescription drug costs for patients and health plans.
Do drug pricing transparency laws lower prescription costs for patients?
Not immediately — but they generate data for targeted interventions. Over time, transparency data supports biosimilar promotion, price negotiation programs, and upper payment limits. The Inflation Reduction Act's Medicare drug negotiation program is expected to reduce out-of-pocket costs for Medicare patients who rely on prescription drugs on negotiated drugs.
Which states have strong drug price transparency laws?
Oregon, California, and Minnesota have enacted comprehensive prescription drug pricing transparency acts. The National Academy for State Health Policy (NASHP) tracks these laws state by state, showing what each state requires of manufacturers and PBMs in terms of reporting and price increase disclosure.
How can I see drug pricing transparently as a patient right now?
Use RxDiff or GoodRx to compare real drug prices at pharmacies near you for free. Your insurer's member portal may also show your expected cost before you fill. HHS publishes drug pricing transparency data at HHS.gov for federally reported information.
Medical Disclaimer: This content is for informational purposes only. Always consult your healthcare provider. Use RxDiff to compare current drug prices in your area.